Literature DB >> 10746926

New surgical and catheter-based modifications of the Maze procedure.

J L Cox1, N Ad.   

Abstract

There is currently an intense interest in applying the principles of the Maze procedure in a less invasive manner so that a wider group of patients with atrial fibrillation can be treated safely and effectively. These efforts have centered around surgical attempts to curtail the number of lesions placed in the atria at the time of valve surgery and catheter-based attempts to re-create a part or all of the Maze procedure with radiofrequency ablation. Thus far, these techniques remain highly experimental and largely without merit. Many of the problems that we encountered several years ago in developing the surgical Maze procedure are now being repeated in patients undergoing these highly experimental and inadequately evaluated procedures. Nevertheless, there are occasional flashes of promise with some of these approaches. Moreover, it is clear that only a miniscule percentage of the patients with atrial fibrillation will ever become candidates for the open-heart Maze procedure as it is now performed. Therefore, the continuing struggle to relieve the invasive downside of the Maze procedure is warranted but with the caveat, especially to our cardiologist colleagues, to proceed with caution.

Entities:  

Mesh:

Year:  2000        PMID: 10746926     DOI: 10.1016/s1043-0679(00)70020-7

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  10 in total

Review 1.  Surgical ablation of atrial fibrillation.

Authors:  A Marc Gillinov
Journal:  J Interv Card Electrophysiol       Date:  2005-07       Impact factor: 1.900

2.  Outcome of concomitant left atrial ablation during valvular heart surgery: an African perspective.

Authors:  Dambuza Nyamande; Risenga F Chauke; Siphosenkosi M Mazibuko; Shere P Ramoroko
Journal:  Cardiovasc J Afr       Date:  2021-09-13       Impact factor: 0.802

Review 3.  Alternatives to warfarin for thromboembolism prophylaxis in nonrheumatic atrial fibrillation.

Authors:  Ramin Artang; Humberto Vidaillet
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

4.  Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.

Authors:  Akshat Saxena; Diem Dinh; Jim Dimitriou; Christopher Reid; Julian Smith; Gilbert Shardey; Andrew Newcomb
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

Review 5.  The Cox-Maze procedure: history, results, and predictors for failure.

Authors:  Niv Ad
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

Review 6.  New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.

Authors:  Stanley Nattel; Paul Khairy; Denis Roy; Bernard Thibault; Peter Guerra; Mario Talajic; Marc Dubuc
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  The hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source.

Authors:  Mark La Meir; Sandro Gelsomino; Roberto Lorusso; Fabiana Lucà; Laurant Pison; Orlando Parise; Francis Wellens; Gian Franco Gensini; Jos Maessen
Journal:  J Cardiothorac Surg       Date:  2012-07-19       Impact factor: 1.637

8.  Arrhythmogenicity of the coronary sinus.

Authors:  Demosthenes G Katritsis
Journal:  Indian Pacing Electrophysiol J       Date:  2004-10-01

9.  Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic Valve Disease.

Authors:  Ernesto Koehler Chavez; Alexandre Siciliano Colafranceschi; Andrey José de Oliveira Monteiro; Leonardo Secchin Canale; Evandro Tinoco Mesquita; Clara Weksler; Odilon Nogueira Barbosa; Anderson Oliveira
Journal:  Braz J Cardiovasc Surg       Date:  2017 May-Jun

Review 10.  Maze Procedures for Atrial Fibrillation, From History to Practice.

Authors:  Charles Kik; Ad J J C Bogers
Journal:  Cardiol Res       Date:  2011-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.